TY  - JOUR
AU  - Calvo-Río, Vanesa
AU  - Blanco, Ricardo
AU  - Santos-Gómez, Montserrat
AU  - Rubio-Romero, Esteban
AU  - Cordero-Coma, Miguel
AU  - Gallego-Flores, Adela
AU  - Veroz, Raúl
AU  - Torre, Ignacio
AU  - Hernández, Félix Francisco
AU  - Atanes, Antonio
AU  - Loricera, Javier
AU  - González-Vela, M C
AU  - Palmou, Natalia
AU  - Hernández, José L
AU  - González-Gay, Miguel A
PY  - 2016
DO  - 10.1016/j.semarthrit.2016.03.002
UR  - http://hdl.handle.net/10668/9980
T2  - Seminars in arthritis and rheumatism
AB  - To assess the efficacy of golimumab (GLM) in refractory uveitis associated to spondyloarthritis (SpA). Multicenter study of SpA-related uveitis refractory to at least 1 immunosuppressive drug. The main outcome variables were degree of anterior and...
LA  - en
KW  - Anti-TNF-α therapy
KW  - Golimumab
KW  - Refractory
KW  - Spondyloarthritis
KW  - Uveitis
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - Female
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Male
KW  - Middle Aged
KW  - Spondylarthritis
KW  - Treatment Outcome
KW  - Uveitis
TI  - Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients.
TY  - research article
VL  - 46
ER  -